Friday, March 22, 2013 11:12:18 PM
$0.2000 5,000 OBB 14:57:50
$0.2000 2,200 OBB 14:57:28
$0.1500 10,000 OBB 12/07
$0.1500 5,000 OBB 12/07
$0.1500 5,000 OBB 12/07
$0.1500 250 OBB 09/18
$0.2000 250 OBB 09/10
$0.1500 200 OBB 09/10
$0.2000 200 OBB 08/27
$0.1800 5,000 OBB 05/22
$0.1800 5,000 OBB 05/22
$0.2000 5,000 OBB 05/02
$0.2500 5,000 OBB 04/30
$0.2500 2,376 OBB 04/30
$0.2600 5,000 OBB 04/25
$0.3500 974 OBB 04/09
$0.3500 1,500 OBB 04/09
$0.3000 150 OBB 04/05
$0.3000 4,850 OBB 04/05
$0.3000 10,000 OBB 04/05
$0.3000 5,000 OBB 04/05
$0.3000 100 OBB 04/05
$0.3000 5,000 OBB 04/05
$0.3000 5,000 OBB 04/05
$0.2000 5,000 OBB 04/05
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM